Evidence map›Paper›PMID 28371326›Full record

ArticleJournal of cellular and molecular medicine2017

Susceptibility loci for metabolic syndrome and metabolic components identified in Han Chinese: a multi-stage genome-wide association study.

Yimin Zhu, Dandan Zhang, Dan Zhou, Zhenli Li, Zhiqiang Li, Le Fang, Min Yang, Zhongyan Shan, Hong Li, Jianhua Chen and 24 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 4 pooled it
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 4 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. ACAD10 and ACAD11 allow entry of 4-hydroxy fatty acids into β-oxidation.Cellular and molecular life sciences : CMLS · 2024
    Article
  16. Article
  17. Article
  18. Association of lipoprotein lipaseArchives of endocrinology and metabolism · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 11 institutions in 2 countries.

Yimin ZhuDepartment of Epidemiology & Biostatistics, Zhejiang University School of Public Health, Hangzhou, Zhejiang, China.
Dandan ZhangDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Dan ZhouDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Zhenli LiDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Zhiqiang LiBio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
Le FangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, China.
Min YangDepartment of Nutrition and Food Safety, Zhejiang University School of Public Health, Hangzhou, China.
Zhongyan ShanThe Endocrine Institute and Liaoning Provincial Key Laboratory of Endocrine Diseases, Department of Endocrinology and Metabolism, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Hong LiDepartment of Endocrinology, Sir Run Run Shaw Hospital Affiliated to School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Jianhua ChenBio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
Xianghai ZhouDepartment of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
Wei YeKey Laboratory of Laboratory Medicine, Ministry of Education of China, School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Senhai YuDaicun Town Community Health Service Center, Xiaoshan District, Hangzhou, Zhejiang, China.
Huabin LiXiaoshan District Sixth People's Hospital, Hangzhou, Zhejiang, China.
Libin CaiXiaoshan District Third People's Hospital, Hangzhou, Zhejiang, China.
Chengguo LiuPutuo District People's Hospital, Zhoushan, Zhejiang, China.
Jie ZhangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, China.
Lixin WangZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, Zhejiang, China.
Yaxin LaiThe Endocrine Institute and Liaoning Provincial Key Laboratory of Endocrine Diseases, Department of Endocrinology and Metabolism, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Liansheng RuanPutuo District People's Hospital, Zhoushan, Zhejiang, China.
Zhanhang SunPutuo District People's Hospital, Zhoushan, Zhejiang, China.
Shuai ZhangDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Hao WangDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yi LiuDepartment of Epidemiology & Biostatistics, Zhejiang University School of Public Health, Hangzhou, Zhejiang, China.
Yuyang XuDepartment of Epidemiology & Biostatistics, Zhejiang University School of Public Health, Hangzhou, Zhejiang, China.
Jie LingDepartment of Epidemiology & Biostatistics, Zhejiang University School of Public Health, Hangzhou, Zhejiang, China.
Chunxiao XuDepartment of Epidemiology & Biostatistics, Zhejiang University School of Public Health, Hangzhou, Zhejiang, China.
Yan ZhangDepartment of Epidemiology & Biostatistics, Zhejiang University School of Public Health, Hangzhou, Zhejiang, China.
Duo LvDepartment of Epidemiology & Biostatistics, Zhejiang University School of Public Health, Hangzhou, Zhejiang, China.
Zheping YuanDepartment of Epidemiology & Biostatistics, Zhejiang University School of Public Health, Hangzhou, Zhejiang, China.
Jing ZhangDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yingqi ZhangDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yongyong ShiBio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China.
Maode LaiDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Zhejiang University · CNShanghai Jiao Tong University · CNZhejiang Center for Disease Control and Prevention · CNZhejiang Lab · CNZhoushan Hospital · CNFirst Hospital of China Medical University · CNHangzhou Xixi hospital · CNCommunity Health Center · USPeking University People's Hospital · CNThird People's Hospital of Hangzhou · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome (MetS), a cluster of metabolic disturbances that increase the risk for cardiovascular disease and diabetes, was because of genetic susceptibility and environmental risk factors. To identify the genetic variants associated with MetS and metabolic components, we conducted a genome-wide association study followed by replications in totally 12,720 participants from the north, north-eastern and eastern China. In combined analyses, independent of the top known signal at rs651821 on APOA5, we newly identified a secondary triglyceride-associated signal at rs180326 on BUD13 (P

Indexed as

AdultAlcohol DrinkingAldehyde Dehydrogenase, MitochondrialAllelesApolipoprotein A-VChinaFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansMaleMetabolic SyndromePolymorphism, Single NucleotideRNA-Binding ProteinsTriglyceridesAldehyde Dehydrogenase, MitochondrialALDH2 protein, humanApolipoprotein A-VBUD13 homolog protein, humanRNA-Binding ProteinsTriglyceridesgene-environment interactiongenome-wide association studymetabolic syndromesecondary signalsingle-nucleotide polymorphism

Identifiers

PMID28371326
PMCPMC5431133
OpenAlexW2600693125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.